Seeking Alpha

BioCryst Pharmaceuticals (BCRX) -4.1% premarket after announcing it will lay off 50% of its...

BioCryst Pharmaceuticals (BCRX) -4.1% premarket after announcing it will lay off 50% of its workforce as part of a restructuring program aimed at cutting costs while advancing its antiviral program and its program for hereditary angioedema, an immune system disorder.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs